News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
426,286 Results
Type
Article (31550)
Company Profile (94)
Press Release (394642)
Section
Business (118570)
Career Advice (790)
Deals (18764)
Drug Delivery (59)
Drug Development (56122)
Employer Resources (68)
FDA (13093)
Job Trends (10009)
News (211523)
Policy (21701)
Tag
Academia (2175)
Africa (425)
Alliances (30863)
Alzheimer's disease (815)
Approvals (13037)
Arizona (97)
Artificial intelligence (45)
Asia (26793)
Australia (4068)
Bankruptcy (152)
Best Places to Work (7810)
Biotechnology (62)
Breast cancer (45)
C2C Services and Suppliers (61773)
California (1126)
Canada (599)
Cancer (368)
Career advice (660)
Cell therapy (78)
China (109)
Clinical research (45349)
Collaboration (85)
Colorado (54)
Connecticut (52)
COVID-19 (1824)
Cystic fibrosis (47)
Data (251)
Diabetes (58)
Diagnostics (3898)
Drug pricing (53)
Earnings (39517)
Employer resources (60)
Europe (52294)
Events (59194)
Executive appointments (111)
FDA (13284)
Florida (195)
Funding (84)
Gene therapy (54)
Georgia (40)
GLP-1 (329)
Government (3438)
Healthcare (14179)
Hotbed/Location (284932)
Idaho (38)
Illinois (204)
Indiana (114)
Infectious disease (1848)
Inflammatory bowel disease (72)
Interviews (91)
IPO (7755)
Job creations (2302)
Job search strategy (618)
Kansas (70)
Layoffs (196)
Legal (4094)
Liver cancer (49)
Lung cancer (89)
Manufacturing (50)
Maryland (326)
Massachusetts (828)
Medical device (12925)
Medtech (12929)
Mergers & acquisitions (10992)
Metabolic disorders (173)
Michigan (66)
Minnesota (153)
Neuroscience (908)
New Hampshire (49)
New Jersey (399)
New York (408)
NextGen Class of 2024 (4858)
Non-profit (3609)
North Carolina (384)
Northern California (509)
Obesity (107)
Ohio (79)
Opinion (72)
Patents (49)
Pennsylvania (394)
People (37339)
Phase I (13360)
Phase II (19933)
Phase III (15569)
Pipeline (80)
Postmarket research (1842)
Preclinical (4368)
Rare diseases (88)
Real estate (4184)
Regulatory (14907)
Research institute (2011)
Resumes & cover letters (112)
South America (625)
Southern California (479)
Startups (2426)
Texas (172)
United States (5520)
Vaccines (342)
Washington State (104)
Weight loss (93)
Date
Today (75)
Last 7 days (461)
Last 30 days (1625)
Last 365 days (23926)
2024 (16688)
2023 (25880)
2022 (34679)
2021 (37287)
2020 (36642)
2019 (33132)
2018 (25389)
2017 (21405)
2016 (20915)
2015 (24350)
2014 (18354)
2013 (15274)
2012 (16657)
2011 (16893)
2010 (15099)
426,286 Results for "tufts medical center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
60 Degrees Pharmaceuticals, Inc. announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients.
May 30, 2024
·
11 min read
Press Releases
Tufts Medical Center Becomes First Hospital in Massachusetts to Adopt MOLLI Surgical’s Breast Cancer Technology
July 18, 2024
·
2 min read
BioCapital
First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind
60 DegreesPharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company” or 60 Degrees Pharmaceuticals), a pharmaceutical company focused on developing new medicines for infectious diseases, announced that the first patient has been enrolled in a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of tafenoquine in treating babesiosis in humans.
June 27, 2024
·
10 min read
Business
Watertown Regional Medical Center Partners with HOPCo To Enhance Orthopedic and Spine Services
Watertown Regional Medical Center and Healthcare Outcomes Performance Company have joined forces to provide top-tier orthopedic and spine care for patients.
June 19, 2024
·
3 min read
Business
QT Imaging Holdings’ Technology Advances Medical Imaging Research at the University of Oklahoma’s Health Stephenson Cancer Center
QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.
June 24, 2024
·
5 min read
Business
OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center
OKYO Pharma Limited is pleased to announce a new agreement with Tufts Medical Center to conduct a 40-patient open-label clinical trial evaluating the efficacy and safety of OK-101 in patients with neuropathic corneal pain (“NCP”).
July 28, 2023
·
6 min read
Deals
Alcanza Clinical Research Acquires Innovation Medical Research Center
Alcanza Clinical Research, a mission-focused investigator site network, has acquired Innovation Medical Research Center, a multi-specialty clinical research center.
April 9, 2024
·
1 min read
FDA
The FDA Needs a Dedicated ‘Center for Rare Diseases’
The agency’s inertia and bureaucratic roadblocks are throttling hope for millions of patients. A new center of excellence would provide a solution.
September 3, 2024
·
6 min read
·
Henry I. Miller
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Pharm Country
ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene
ANEW MEDICAL, INC. announces a strategic partnership with Drs. Makoto Suzuki, Craig and Bradley Willcox, Richard Allsopp, and Michio Shimabukuro of Japan’s Okinawa Research Center for Longevity Science for the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.
June 27, 2024
·
6 min read
1 of 42,629
Next